Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,829 | -3,678 | -3,411 | -2,672 | -3,004 |
| Depreciation Amortization | 842 | 419 | 235 | 11 | 15 |
| Accounts receivable | 30 | -31 | -76 | 64 | -174 |
| Other Working Capital | 1,656 | 1,448 | 1,552 | 740 | 1,369 |
| Other Operating Activity | 65 | 311 | 638 | 290 | 423 |
| Operating Cash Flow | $-1,237 | $-1,531 | $-1,062 | $-1,566 | $-1,371 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5 | -46 | N/A | -20 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 2 |
| Investing Cash Flow | $N/A | $-5 | $-46 | $N/A | $-18 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,200 | 1,257 | 468 | 1,549 | 1,700 |
| Common Stock Issued | N/A | 365 | 831 | N/A | N/A |
| Other Financing Activity | 0 | -43 | -242 | 0 | -265 |
| Financing Cash Flow | $1,200 | $1,580 | $1,056 | $1,549 | $1,435 |
| Beginning Cash Position | 50 | 6 | 57 | 74 | 29 |
| End Cash Position | 13 | 50 | 6 | 57 | 74 |
| Net Cash Flow | $-37 | $44 | $-51 | $-17 | $46 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,237 | -1,531 | -1,062 | -1,566 | -1,371 |
| Capital Expenditure | N/A | -5 | -46 | N/A | -20 |
| Free Cash Flow | -1,237 | -1,536 | -1,107 | -1,566 | -1,391 |